Transplante de Medula Óssea
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n1.3234Palabras clave:
Trasplante de Médula Ósea, Neoplasias/terapia, Trasplante AutólogoResumen
Artigo de opinião, de Mary Evelyn Dantas Flowers do Instituto Nacional de Câncer (INCA) sobre a função, a finalidade e os resultados obtidos com o transplante de medula óssea (TMO).
Descargas
Citas
Storb R, Thomas ED, Buckner CD, et al. Marrow transplantation for aplastic anemia. Semin Hematol. 1984; 21 (1): 27-35.
Bortin MM, Gale RP. Current status of allogeneic bone marrow transplantation: a report from the international bone marrow transplantation registry. Clinical Transplant 1986 — Terasaki, P.l. (ed) (in Press).
Thomas ED, Ciift RA, Buckner CD. Marrow transplantation for patients with acute non lymphoblastic leukemia who achieve a first remission. Cancer Treat Rep 1982; 66: 1463-1466.
Clift RA, Buckner CD, Appeibaun FR, Thomas ED. Stragies for the treatment of acute nonlymphoblastic Ieukemia with marrow transplantation. Exp Hematol, 1986; 14 (6): 486. (Abstract 411).
Thomas ED. Marrow transplantation for malignant disease. J Ciin Oncol, 1983; 1 (9): 517-531. DOI: https://doi.org/10.1200/JCO.1983.1.9.517
Sokai JE. Evaluation of survival data for chronic myelocytic leukemia. Am J Hematol, 1976; 1: 493-500. DOI: https://doi.org/10.1002/ajh.2830010414
Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for Ieukemia. N EngI J Med, 1986; 314 (12): 729-735. DOI: https://doi.org/10.1056/NEJM198603203141201
Kaizer H, Yeager AM, Braine HC, et al. Autologous bone marrow transplantation (ABMT) in acute Ieukemia using ex vivo marrow treatment with 4-Hydroperoxycyclophos-phamide (4HC). 1986: 218. (Abstract p. 27). DOI: https://doi.org/10.1016/0145-2126(86)90127-X
Dicke KA, Jagannath S, Spitzer G, et al. The role of autologous bone marrow transplantation in various malignances. Semin Hematol, 1984; 21 (2): 109-122.
Weiden PL, Flournoy N, Sanders JE, et al. Anti-leukemia effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc, 1981; 13: 248-251.
Reisner Y, O'Reilly RJ, Kapoor N, et al. Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soy bean agglutinin. Lancet, 1980; 2: 1320-1324. DOI: https://doi.org/10.1016/S0140-6736(80)92394-6
